IFNL3 and Cirrhosis: Compared to the non-SVR patients (n = 92), the SVR patients (n = 427) exhibited lower HCV RNA, HOMA-IR, and C-peptide levels, lower genotype 1 HCV infection and cirrhosis rates, a higher rate of the IFNL3-rs12979860 CC genotype, and higher platelet counts.